depression with glp 1 The risk of depression, anxiety, and suicidal behavior in patients obesity on glucagon like peptide-1 receptor agonist therapy New Study: GLP-1s REDUCED Depression
Description
Supports Appetite Control and Weight Management
We've had a few enquiries about this "weight-loss" product this week
Medical Director Guy Slater explains the real risks with GLP-1's and pancreatitis and why they remain safe and effective for weight loss.
Understanding the difference between expected slowing and pathological delay helps patients use semaglutide and tirzepatide safely
GLP-1 agonists work by regulating appetite hormones and blood sugar, addressing both menopause-specific weight gain and metabolic slowdown
Understanding current research, milk transfer data, and alternative timing strategies helps inform your decision about weight management during breastfeeding
